| Name | 4-{3-[3-Cyano-4-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl}-2-fluoro-N-(2H3)methylbenzamide |
|---|---|
| Synonyms |
4-{3-[3-Cyano-4-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl}-2-fluoro-N-(2H3)methylbenzamide
Benzamide, 4-[3-[3-cyano-4-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-(methyl-d3)- |
| Description | Enzalutamide D3 is a deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C21H13D3F4N4O2S |
| Molecular Weight | 467.454 |
| Exact Mass | 467.111847 |
| LogP | 2.13 |
| Index of Refraction | 1.630 |